Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
pred escapes from the evil shorts
watch video
update from noted financial publication that has recommended eglg during the past few months
http://saadvisory.com/update/archive/Sept-02-2019.htm
heard via the grape vine of rumors that as it has been telegraphed that a board meeting is next week either Tuesday or Wednesday and a new board member is going to be named. The name of that person is a worldwide individual that is iconic in the Tech world!
True or false! I guess we will see next week.
Also for 100th time there is "groundhog day" belief that the scum at NASDAQ will release from the chains of pink sheet horror!
many assumptions
1. we could get announcement anyday! Or sometime before Xmas!
2. we get denial and i believe the stock could go to $1 short term!
3. we could get denied and the stock rallies because we are free of NASDAQ and now the company can put out important data points and 8k's. then the stock rally's hard and we list on the NYSE
4. FBI and SEC file charges against HB and conspirators the stock rally's hard because the scam is out in the open.
5. Crystal ball ( we get the uplift announcement either end of days Thursday or Friday and we trade next Thurday.
6 If listing happens all of these negative souls will move on especially RL
CT!
7. Finally, all of us that have acquired PAS begin to recover ( PRED anxiety syndrome)
So Thomas ! many of us appreciate your comments about PRED and most believe you have an inside track to the workings of PRED.
For all the endless time spent for PRED to get listed on this rigged exchange WHY does not or cannot PRED . "say do it or release us!
Nasdaq must know the damage that has been created, but from all angles they really don't care!
We have a pic of the CEO some 10 days ago on the floor of the nasdaq, but still we have nothing but assumption.
I repeat either list us or free us! You can say they want to stay within the NASDAQ listing , but seriously - the SEC form 10 gave us a clearance of ethics and now for some 2 months we play "ring around the rosy"
The shareholders have been screwed with limit meat and bone info and been painfully dragged along the yellow brick road to know where.
The PR firm in LA is totally useless! I spoke to MS. Cain ( worthless) she was not even aware of the PIC @ the NASDAQ! Now that is impressive!
slither dither ( that is right we all having be dithering) but not the snakes
1. Don't believe their earnings are going to be positive at all. I do believe that they will be cash flow +!
People says amazing ER report i doubt it!
Regardless, i remain extremely bullish on the cmpy and we have all developed PAS ( PRED anxiety syndrome )
We have all been tormented by zacks, HB, shorts ( many of these float around this thread tormenting us and let us not forget NASDAQ)
NASDAQ has hurt us the worst. I say either uplift us or let us go so we can proceed to an exchange that wants us!
The NYSE is much cheaper and i am sure we could sail thru.
The one aspect that should not be over looked in my opinion is that PRED has NO venture funds, Unicorn fund or any funds that have funded the company over the years and only wait to go public so they can reap the profits of early participation. I assume these funds pressure NASDAQ to list rapidly.
Look at some of the garbage that has been listed lately UBER, lyft, We work (not sure out yet, but close) their numbers are terrible. How about the dog food BYND (plastic hamburgers -open with a $12 billion market cap with tiny revenues ( now only $6 billion )
The whole thing is a scam run not so honest people. These large funds surely pressure NASDAQ, but PRED has nothing to offer because the funds are not in the deal so who cares?
This whole thing has been disgraceful .
Here is another disgusting and worthless conversation that i had with PRED's PR firm in LA. I talked to Ms. Cain today and can believe that this brainy west coast women of distinction did not even know about the visit to the NASDAQ and never saw the picture. Now that is well $ spent.
PRED has amazing management, but not sure about their market sense. I guess you cannot have it all
Jerry Kramer just another example of honest reporting about PRED. Thomas has and had a great offering about pred, but so does this gentleman
this is a dangerous stock! The amount of death spirals in this deal is multiple pages worth-too many to count. NO revenue! huge negative equity and countless shares outstanding. I read 94 million , but other places says 40 million. The company's management has lied for almost 6 months.
First it is $200 million then $100 million then $50 million and now $20 million. Week after week after week more and more bullsh+t!
Hard to trust if you cannot verify!
One has to wonder why it would take money promised to take so long? Answer is that it is a possible scam! The management has made up excuse after excuse! You cannot keep yelling fire in the movie theater
Thomas- I am curious why would NASDAQ let you release the photo?
In your opinion do you think that regardless of the price that they will stop screwing with this company and issue the ok?
NASDAQ know what they are doing to this stock! U have to wonder why they
continue to torture the shareholders, management and progress that will follow listing?
Everyone on this thread except for the bashers have truly been tortured- including yourself.
Everyone appreciates you being the Elephant in the room
thanks
thomas hbs where did you get this famous pic from?Were u there?
it is called catalysts! so tired of green purple candle with a cherry on top with a triangle female head upside down with 3 days on your back with a bottle of vodka. Then a fishing line with a wiggler that is yellow but inside a dog formation and a In and Out burger with out fries and a chicken wishbone!
So that is where we are at today because of all the above garbage
One more thing F=ck the shorts- it is just endless
This stock would have been slaughtered today if it was not for the NASDAQ pic! That was the catalyst and the stupid chart followed. This the head the wags the tail!
I appeciate your insight! So what does this picture mean?
This pic was taken on the 15th of August.
NASDAQ should either list or PRED should go away. The damage done to shareholders has been devastating.
As you know first it was Zack's, the H-bomb,then no news, no nasdaq listing and of course the 'shorts' that have destroyed many!
Many left with huge losses only never to return. The many on the team of PRED had been rinsed and repeat many times and caused a sour taste.
Many of us have remained with huge losses and have felt that management could give a damn.
This picture indicates listing i assume, when is still the question?
It is called PRED anxiety
Thomas HBS- so appears you are the same large shareholder that flew into SCL when the Hit job by H happened. Now you release a pic of the leader of the company at the NASDAQ.
I have heard that you might be an integral puzzle piece of the PRED development.
So you release this picture does this not create a situation that pics were not allow for the very reason that NASDAQ does things secretly. Does this photo compromise the situation temporarily ?
Can i assume that the listing announcement will happen tomorrow because this has been released?
Brad going to Hong Kong - not sure that is the wisest business decision because the airport is going to be disrupted and flighst might be diverted.
Interesting photo! Raises the spirits of all of us that have developed PRED anxiety ( maybe the company could come up with a genetic test)
thanks for your interest in the small investor
I lived in SLC from 1976 to 2007 ( ruined by population growth)
i am 110% a capitalist! I believe in the system, but this treatment of PRED by the shorts (naked) and the feckless agenda is beyond shameful.
Management pull the plug on this charade. They are never going to list you and the shorts will just try to kill you stock. It is funny just as NASDAQ was about to list us ~ the H report came out and they have not stopped. H continues to made libelous charges against PRED and this game continues.
Watching how endless stock is continually offered. I watch when the stock was at $2.06 and 20k went by in 3 million/ I watch another 10k at the end of the days then the best 2 minutes before the close. 3:58 20k @ 2.02-2.04 and then it was over $1.99 at the close.
IF there is some worthless rule of $2 minimum we are now 2 days below that.
All day the buyers trying to get a small positive move, but the selling never ever stops.
Management if you read all this garbage on this site! GROW SOME BALLS AND SAY F+CK NASDAQ! ENOUGH IS ENOUGH
THIS HAS NOTHING TO DO WITH SHORT TERM OR LONG TERM THIS HAS TO DO WITH THE TOTAL SCREWING SHAREHOLDERS AND INVESTORS
Maybe PRED can produce a test for PRED anxiety!
Not even sure why they stay with the nasdaq~ should just say "screw you" and go and get listed on NYSE. This way this short game would become more controllable !
The company is screwing themselves and the shareholders are of course getting screwed. Think how many investors that have bought pred and because of lack of direction except for down they have sold. Or how about some investors would be happy to just break even.
This is such a cluster F+ck, but we must hang in there because there are
huge developments behind the scene that sooner than later will be released.
We are now in the drip mode again! You would think that by now management would figure it out that press releases ( a few/wk) keeps the zoo happy!
NASDAQ is shameful , H-bomb is just plain evil. They knew PRED was just about to get listed so they released their garbage. Then management had to answer all the question that were brought up-( took weeks)
I hear latest question answered a few week ago
You have to wonder if they are partnering with the NASDAQ because there are so many players are short the stock.
Either list us or we fly over to the NYSE
http://www.clarinova.eu/
huge amount of information! treasure trove
tonnes of tailings 17,780,000
AS our friend PRED continues to be stuck in quicksand. Our other little friend ELGL ( Merle started pred and has put together elgl)
The press release from elgl is amazing- just released
This is just part of their many divisions that will explained and shown to investors very soon
PRED- many management of pred can test for PRED Anxiety that most of us have. We are at the slow drip again with nasdaq anxiety as well. It is like Double dose of hell
last Q 40 mil shs outstanding now 94,000,000 lots of death spirals
promised for months 200 million then 100 million then 25 million
only thing investors got was 60,000,000 additional shs
run run fast garbage
sec should be contacted
june 6th market was 275million shares x $5+ so the market cap was well above $50 million so why would they file stating market cap was below $50 million?
Why it has not been listed could be 100 reasons! Hopefully one day soon we will get the decision .
I believe that there is plenty of information ready to be released, but the nasdaq listing has held up the "meat on the bone" instead just has served us the meat!
One of these day this stock i believe will run and one must be in prior to the biggest bang!
Here is another week upon us and closing in on the end of August!
It is like drip drip drip drip
Well for the week up .20 on 2 very positive presser. H-bomb puts out desperation . Another week and still NO NASDAQ listing. It can always be next week or so. Volume not very high- you know dog-days-of -summer.
There will be a catalyst that takes us higher again. This Pink sheet listing is a real detriment. Once listing happens institutions can pour into PRED and brokerage firm can announce relationships with the company.
I say, " either list us or release us" then we can go to the NYSE or OCTQX- both will allow institutional listing.
IT has been extremely frustrating for all of us. Too see the stock goes from $1.00-$6.90 back $1.53 and now hovering around $2.50- Huge profits lost and many investors have huge paper losses.
The only real answer here is to be patient because there will be a catalyst out there will shake the shorts, cause interest for funds, as stock goes higher there will be a frenzy by those who have been waiting and don't want too miss out and brokerage coverage. The Unicorn is out there !
The connection between PRED and ELGL
The initial developer of both of these two companies puts the puzzle parts together . Look at pred- this management team was grown into the AAA+ group and after time we ended up with PRED and their successes. I have heard via our friendly parrot that next week pred goes BOOM - we will see!
We all have been waiting for nasdaq listing and "meat-on-the-bone announcement that will drive us back to the $6 level.
On-the-other-hand ELGL ~if you read the pressers you can see the same footprint that was integrated into PRED!
ELGL's initial management are movers and shakers in Hollywood. The lawyer represents A-lister actors. The other director was the executive producer of the movie "fury" an excellent WWII movie about a tank ( Brad Pitt -starred) grow $212 million
You must ask yourself why are these 2 people getting involved with this company?
Same reason why did all these high end persons get involved with PRED?
ELGL has just acquired a huge asset base not fully disclosed, but again the puzzle pieces are being put together at the ground floor level and @ .27 could easily appreciate 10X the current level..
PRED- in time could also appreciate 10X- The endo test kit, the Osteoarthritis study, their stem cell products, their joint ventures, their huge genetic library and countless other things that we don't even know about.
Investing 30 years ago was all about long term dreams today it only last 24 hours. Be patient and the rewards will huge for both
before you beat this deal up. Just like PRED the cmpy is being built with quality management and directors. Do you really believe that the 2 directors recently announced want to get involve with a scam?
Top tier law firm for A- list movie stars
An executive movie producer - example of highest rated film "fury" with Brad Pit total gross over $200,000,000.00
The announcement was vague, but the cmpy will build upon each and every
release. This stock is going much higher
updated recommendation on ELGL-non paidBrief update on PRED ~ $2.30
Brief update on ELGL~ $.29
PRED~
We first recommended PRED on April 22nd and then again on April 29th 2019. If you have not reviewed our complete recommendation go to our website http://www.saadvisory.com and review the email alerts.
It has been a wild ride and it has been very profitable for some investors and a nightmare for other.
We initially recommended PRED originally at $2.13 only to see it explode to $6.90 a short period later only to collapse to a recent price of $1.53 and is currently back to $2.30.
It is our opinion nothing has changed except the fact that unforeseen events have (black swans) all lined up at the same time and temporarily crumbled the share price. The future expectations and goals of the current management team has not changed.
We first had a incomplete recommendation by Zack's, then the "hit" job by "H", then the continued news blackout because of NASDAQ listing and the endless "shorting" of the shares.
Last week management decided to begin the process of releasing information regardless of their pending NASDAQ listing due to the collapse of the share price during the past 30+ days.
It is not the time to panic, but in our opinion investors should keep their eye on the ball!
We truly believe that PRED at current levels offers investors even a better price than our original recommendation because additional news had been released.
We anticipate in the near term exciting news will be released that will drive this stock much higher than the currently depressed levels.
If you get nervous just review again the AA+ management team, the law firm that represents them (top 4 in the nation), the current collaborations, pending NASDAQ listing, the huge short position and the endless potential of genetic investigation that can and could lead to medical cures of the many diseases that plague us!
Note: We believe that the initial delay was due to additional questions that NASDAQ needed clarified. If NASDAQ does not happen there are other options. They could go on the OTCQX or even the NYSE. In our opinion this delay is just a bump on the yellow brick road.
If NASDAQ is going to list we believe it will happen within 2 weeks.
We continue to rate PRED with a strong buy at current levels for extra ordinary upside potential short and long term.
ELGL was initially recommended on or about June 12th 2019.
You can review our initial recommendation below.
Since that time management has aggressively delivered on their plan of action.
The company recently opened their corporate office within 5 miles of the Beverly Hills area of California and has named a few of their directors
Please review the 7/30/19 and 8/01/19 press releases and read between the lines.
These puzzle pieces are being put together just as PRED was formulated. We anticipate in the near term additional information released by management will drive this micro-cap much higher.
. We are very aware that there are no audited financials at this time and the company is not fully reporting, but we believe that is going to change near term.
The share price continues to trade at our initial recommended price so there is still opportunity for investors to grab attractively priced shares (.29).
We continue to rate ELGL with a strong, but speculative buy rating at current levels for short and long term appreciation. If this opportunity works out as we anticipate then we could easily see 10X your initial investment.
ELEMENT GLOBAL, INC ELGL~.29
On June 12, 2019 we featured a very speculative , but at the same time an intriguing investment opportunity that could reward investor's handsomely.
This company has been in the dark for a number of years and it is hard to decipher what kind of businesses are entwined within the corporate structure of EGLG.
ELGL resembles a simmering volcano that has been rumbling for a period of time and suddenly BOOM! ELGL's rumble has caught the attention of many because some of the same personnel involved with PRED have been thought as initial players in ELGL.
If one was to venture onto the Investorshub.com message board and review the posts on the ELGL's thread it appears that there is plenty under the radar or better yet under the cover of clouds.
During the past 30 days 2 major pressers have been released waking up investors with the belief that a rapid change is coming very soon!
On June 4th management announced a committee to explore potential acquisitions. Then on June 5th the company announces plans to add additional personnel to their "board of directors" and management discussed plans on moving their corporate office to Southern California.
At present there appears to be around 175 million shares outstanding . We don't know where that stock sits or who own it.
There is plenty of documentation concerning this company and it's many subs and involvements. It is a spiderweb of ins and outs and best of all the "giant appears to waking"!
During the recent few months it has quickly run from the low teens to the high .60's and pulled back to the current level twice. We believe the next release or releases will pop and propel ELGL to new highs.
Yes, this is speculative in nature, but it feels like Element Group is ready to surprise the herd with news that will appreciate shares dramatically .
WE MAY BUY, SELL AND OR HOLD AT OUR OWN DISCRETION .We currently own shares in all stocks mentioned..
SUBSCRIPTION INFORMATION:
1 YEAR HARD COPY $250.00
1 YEAR PERSONAL CONVERSATION WITH EDITOR $3000.00- ANYTIME ACCESS VIA PHONE
$1800.00 ANYTIME ACCESS VIA PHONE FOR 6 MONTHS- CALL FOR INFORMATION- WE CALL YOU AND YOU CAN CALL US+ FIRST CALL ON RECOMMENDATIONS PRIOR TO ALL OTHERS.
1 TRIAL "NEW" STOCK PICK BEFORE RELEASED VIA EMAIL $100.00- INCLUDE PHONE NUMBER.
SEND CHECK: S A ADVISORY, 4708 S HOLLADAY BLVD, S L C , UTAH 84117
QUESTIONS 949 922 9986
S.A.Advisory, 4708 s Holladay blvd, PHONE 9499229986/8012724761, salt lake city, UT 84117
SafeUnsubscribe™ naga1@ix.netcom.com
Forward email | Update Profile | About our service provider
Sent by naga1@ix.netcom.com in collaboration with
Constant Contact
Try email marketing for free today!
The http://www.saadvisory.com recommendation was not a promo piece! IT WAS NOT PAID FOR ! DON'T SPREAD RUMORS AND GIVE OUT MISINFORMATION
Every time they say the money is only seconds away the stock justs only to slammed by all the scum that have the toxic converts happy to sell bunches because they have endless paper.
This whole deal is toxic and the management behind the deal are toxic
First it is 200 million then 100 million "almost there" then 25 million and now the latest spin is a few investor's are investing in this scam.
RUN
relax and watch this video
nature at its best
You know GIGO! garbage in garbage out!
Very simple in today's era of digital technology it takes seconds to clear a banking transaction. With all the "snakes and ladders" during the past 6 months the spin is load and crystal clear! First $200 million then $100 million then other investors then more investors then nothing -RUN
What a bunch of garbage! The recent press anticipate, expect, only a matter of time, will not disclose, large investors, banks,term sheets , banks decisions,close and all Bullshit!
The convertible securities are super death spirals. Run as fast as you can because this is plain and simple trash
Well we have 6 straight days down and prior to the stock ran from $1.65 or so to $2.90 and we all know that is history. Most that has touched this stock has gotten burned badly for the time being. to get hit with 4 black swans is truly a feat in itself! First Zacks, shorting, nasdaq deadly quite period that is putting us all in the grave, The H- bomb report, more selling from pained investors and shorts continue to peck away like woody wood pecker. Let us not forget that there has been zero news from Must the company whether because of potential listing ( seem questionable maybe- NASDAQ can do whatever the please) Surely they must realize they and they alone have crushed investors and emptied their pockets.
All you can do is shake your head in disbelief!
At this rate we will be at ZERO by Friday of this week so i assume we are
close to either the bottom or ZERO
Must focus on why bought into this story- chance to average down with attractive pricing or more losses . but again there is a bottom.
stockguru u are 100% correct. i saw all of the same article in the WSJ.
ADPT- difference has agreement with major and got $300 million and of course just did an IPO and raise mucho cash. The difference is management the ADPT management are mostly researchers. One person worked for PFE.
Our management leads and creates.
Gene therapy and manipulation is the wave of the future of medical advancements and cures.
Don't how much more pain is left?
food for thought!
1. Why did TMO form a relationship with this company?
2. Why did all of the AA+ management participate in the company?
3. Why did they hire a top tier law firm that handles such clients such
as Google?
4. Why did they apply for NASDAQ?
5. Why did they hire IQVIA to begin testing of drug for OA of the knee on 200 patients?
6. If a scam why has there been absolutely NO selling by the insiders?
7. Don't forget their Endo test kit?
None of us saw the black swans that obliterated the share price!
1. Zack's half ass report paid by some third party
2. NASDAQ listing that placed us in a void as if we are in Space where know one can here ( was that Alien 1 or Space odyssey)
3. The endless shorting ( either MM's or offshore entities
4. The H-bomb that really killed us.
5. Some 50 days of silence
6 Investor's begin to believe that the top 6 reasons do not exist!
7 Almost at maximum fear
So from $1 to $6.90 back to $2 Everyone was a winner in the beginning when the unicorns pranced around the garden of stock Eden only to misstep and for the time being reside in one of the levels of purgatory
Not being a cry baby , BUT it is truly disgraceful that management appears as well as NASDAQ to not give a damn about current shareholders. The endless shorting and or selling with limited buying because there is absolutely NO news and well as NO listing information. The paper losses are staggering for shareholder at every price level and the sounds are deafening .Shame on management and NASDAQ for the ultimate screw.
The eventual story line is that the wait continues and we fall below $2 again and listing may become more problematic.
I just sit here and shake my head because all of this is out of yours and my control. It is plain ulgy!
I am not selling any of my large position. I am just making a point that many of you i know will agree with
http://www.saadvisory.com was not a promo piece. They were not paid for the recommendation that they made on April 22 and 29 2019
COMPLETE ARTICLE FROM WSJ Are Using Your DNA To Make New Medicine
Partnership between Glaxo and 23andMe has produced six potential drug targets but raises ethical questions
23andMe’s booth at the RootsTech trade show in Salt Lake City, Utah, earlier this year. PHOTO: GEORGE FREY/REUTERS
By Denise Roland
July 22, 2019
Genetic test-kit company 23andMe Inc. has for years used saliva to tell millions of consumers how closely related they are to Neanderthals or whether they are likely to develop diseases like diabetes or Alzheimer’s. Now, it’s fulfilling a bigger ambition: drug development.
For the past year, 23andMe has been sharing its huge trove of genetic data with drug giant GlaxoSmithKline PLC, which took a $300 million stake last summer. That collaboration has so far produced six potential drug targets, and the companies expect to start human trials on at least one candidate drug next year. But it also raises ethical questions about using people’s genetic data to create profitable drugs.
For 23andMe, using genetic data for drug research “was always part of the vision,” according to Emily Drabant Conley, head of business development. Since its founding in 2006, the company has amassed a huge collection of data from the millions of people who have submitted spit samples—and up to $199 each—in return for insights on their genes. The company says it has sold around 10 million test kits and analyzed more than eight million people’s DNA, making it the largest repository of human genetic information in the world.
That information is especially valuable to drugmakers because the majority of 23andMe’s customers also choose to answer questionnaires on their health. Analyzing millions of people’s genetics alongside data on their overall health provides clues on the interplay between genetics and particular ailments, creating potentially fruitful avenues for drug discovery.
For Glaxo, the 23andMe deal is part of a wider effort to use genomic data to hunt for new drugs. The company also is involved in research projects with government-funded genome collections in the U.K. and Finland. It hopes that genomics could help solve a problem that plagues the pharmaceutical industry: a high failure rate in turning promising leads into drugs that work.
“The industry is in a very inefficient place right now,” said John Lepore, who heads early-stage research at Glaxo. “We’re spending tens of billions, but the number of new medicines turning out is not high.” The British company estimates that drugs based on genetic information are twice as likely to succeed in clinical trials as those that aren’t.
DNA Match
Several pharmaceutical companies have partnered with genetic databases to aid their drug-discovery efforts.
Selected genetic databases
and their industry partners
23andMe
8 million
individuals
AbbVie
Alnylam
Amgen
deCODE
Genetics*
1.6 million
AstraZeneca
Biogen
UK
Biobank
500,000
Bristol-Myers Squibb
Celgene
Genentech†
Geisinger
250,000‡
GlaxoSmithKline
Merck & Co
Pfizer
FinnGen
146,630
Regeneron
Sanofi
Mayo
Clinic
100,000‡
Takeda
*Amgen owns deCODE †Part of Roche ‡Target
Source: the companies
Others are making similar bets. Amgen Inc. bought deCODE Genetics, which started out as an initiative to gather genetic data from the Icelandic population, to help it hunt for potential drug targets. Regeneron Pharmaceuticals Inc. is working with dozens of hospitals and research groups seeking clues to the genetic causes of disease.
23andMe has long wanted to use genetic data for drug development. Initially, it shared its data with drugmakers including Pfizer Inc. and Roche Holding AG ’s Genentech but wasn’t involved in subsequent drug discovery. It later set up its own research unit but found it lacked the scale required to build a pipeline of medicines. Its partnership with Glaxo is now accelerating those efforts.
Glaxo expects the collaboration to accelerate the costly and arduous process of finding patients to join clinical trials. Typically, drugmakers rely on advertisements and doctors to spread the word about trials, and not all patients who express an interest are eligible.
One of Glaxo and 23andMe’s targets is a rare mutation in a gene called LRRK2 that raises the risk of developing Parkinson’s. Around one in a thousand people are carriers, which would make them very difficult to find using traditional trial-recruitment tactics. 23andMe has contact details for 7,500 carriers it can invite to participate.
Dr. Lepore estimates that could shave “months, if not years” off the trial-recruitment process.
A 23andMe DNA kit. PHOTO: GEORGE FREY/REUTERS
23andMe asks customers to consent to their genetic information being used for research purposes, and the firm says 80% say yes.
Still, some critics say it isn’t ethical for 23andMe to profit from a database built from the genetic data of paying customers.
“You get this gigantic valuable treasure chest, and people are going to wind up paying for it twice,” said Arthur Caplan, a professor of bioethics at NYU School of Medicine. “All the people who sent in DNA will be paying the same price for any drugs that are developed as anybody else.”
A 23andMe spokesman said its customers are making an informed choice to allow their genetic information to be used in research. The company says it only shares high-level summaries of its data with Glaxo, but the partnership highlights a broader privacy concern: that 23andMe’s customers may not have realized their data would be used by the pharmaceutical industry.
“Consumers really need to think about what they’re getting into,” said Richard Forno, assistant director of the Center for Cybersecurity at the University of Maryland, Baltimore County. “Where’s that data going, and who’s getting it?”
A 23andMe spokesman said customers are sent letters informing them about for-profit collaborations, and that they have the option of withdrawing consent for that research.
For some, the benefits outweigh the drawbacks. Reni Winter-Evans, 64, sent her saliva to 23andMe last year, after a client told her that her missing sense of smell could be an early sign of Parkinson’s. The results revealed she carried the LRRK2 mutation. She subsequently got diagnosed with prodromal Parkinson’s, which means the disease can be detected in her brain but hasn’t yet seriously affected her movement.
Ms. Winter-Evans said she would be an eager participant in a clinical trial targeting LRRK2. “The importance of finding a cure far outweighs my illusion of privacy,” she said.
Corrections & Amplifications
23andMe has analyzed the DNA of more than eight million people. An earlier version of this article and an accompanying graphic incorrectly said the company has analyzed the DNA of more than five million people. In addition, GlaxoSmithKline is among the drug makers working with UK Biobank. An earlier version of the graphic didn’t show that connection. (July 23, 2019)
Write to Denise Roland at Denise.Roland@wsj.com
monitor should post this as a good reference for PRED shareholders.
They have gold in their accounts and don't even know it!
How many genetic samples does PRED own?
The future is here and we will be a player
https://www.wsj.com/articles/23andme-glaxo-mine-dna-data-in-hunt-for-new-drugs-11563879881
this article good easily have pred's name within it
genetic medicine excellent
Hold tight- many don't know what they are holding
yesterday's wall street journal section B1 front page
https://www.wsj.com/articles/23andme-glaxo-mine-dna-data-in-hunt-for-new-drugs-11563879881
if you read the document. Show were it says it has been completed.
If you read carefully there are many documents etc etc that indicates much to get signed sealed and delivered before this happens.
How can you believe anything this company has been spewing during the past 6 months! $200,000,000.00 and that comes with a field of unicorns and 12 virgins on horseback.
It is called GIGO
i count 4 unless i am still on mushrooms
take notice of all the new market makers today!